Endothelial cell signaling in regeneration of the lung
肺再生中的内皮细胞信号传导
基本信息
- 批准号:10506642
- 负责人:
- 金额:$ 16.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAcuteAcute Lung InjuryAddressAdvisory CommitteesAlveolarAlveolar CellAlveolusArchitectureAreaBioinformaticsBiologyBloodBlood VesselsBlood capillariesCOVID-19Candidate Disease GeneCapillary Endothelial CellCarbon DioxideCardiovascular systemCell CommunicationCell Differentiation processCell LineCell ProliferationCellsCellular biologyChronic DiseaseCommunicationCommunitiesComplexDataDevelopmentDevelopment PlansDistalElastasesEndothelial CellsEndotheliumEnvironmentEpigenetic ProcessEpithelialEpithelial CellsFoundationsFunctional RegenerationGasesGenetic TranscriptionHeterogeneityHomeostasisHumanImageImmuneIndividualInfectionInfluenzaInjuryInstitutionInternationalKDR geneKnock-outKnowledgeLigandsLungLung diseasesMalignant NeoplasmsMammalsMentorsMesenchymalMorphogenesisMorphologyMusNatural regenerationOrganOrganoidsOxygenPatientsPennsylvaniaPhasePopulationPositioning AttributeProcessProliferatingPulmonary alveolar structurePulmonary function testsReceptor SignalingRegenerative capacityResearchResearch PersonnelResourcesRoleScientistSignal PathwaySignal TransductionSignaling MoleculeSiteStructureStructure of parenchyma of lungTimeTissuesTrainingUniversitiesVascular regenerationViralWorkalveolar epitheliumcareercareer developmentcell behaviorcell regenerationcell typeendothelial stem cellepigenomicsgenetic approachimprovedin vivoinfluenza infectioninjuredinjury and repairinsightlung injurylung regenerationmouse geneticsnovelpost-doctoral trainingpreventprogenitorprogramspulmonary functionpulmonary vascular cellsreceptorreconstructionregenerativeregenerative therapyrepairedresearch and developmentresponseself organizationsevere injurysingle-cell RNA sequencingskillsstem cellstranscriptome sequencingtranscriptomics
项目摘要
Project Summary
A critical function of the lung at homeostasis is delivery of oxygen to the blood through a process called
gas exchange. When the lung is functioning normally, type I alveolar epithelial cells and capillary endothelial
cells (ECs) lining blood vessels in the distal lung form a tight interface to exchange oxygen and carbon dioxide
between them. However, when the lung is damaged by chronic disease, cancer, or infections such as influenza
or COVID-19, this process can be hindered or even prevented. After lung injury, progenitor cells can regenerate
the cell types required for gas exchange, but cell-cell communication is also essential to form a functional
structure that restores delivery of oxygen to the blood. Development of improved regenerative therapies in the
lung will therefore require a detailed knowledge of not only the specific cell types that are present, but also how
they communicate to drive cell self-organization and morphogenesis. We have shown that capillary ECs in the
distal lung are heterogeneous; one population acts as an EC progenitor and proliferates after acute injury
(CAP2s), while a second population does not proliferate significantly after injury and possesses a larger, more
complex morphology and high expression of signaling molecules (CAP1s). These EC subtypes clearly contribute
differently to regeneration, but how distinct EC fates are established and maintained, the mechanisms that
promote the preferential proliferation of CAP2s, and the signaling function of CAP1s remain unknown. In addition,
the EC signaling mechanisms within the alveolar niche that are required to effect morphogenesis and rebuild the
gas exchange interface remain incompletely understood. The proposed research will further develop my skills in
transcriptomic and epigenomic analysis to address these questions and will integrate these skills with my
previous training in mouse genetics, signaling, and cell behavior to establish a strong foundation on which to
build an independent research career. My research program will focus on the role of EC signaling and behavior
in regeneration of functional alveolar structures in the lung after acute injury. My primary mentor is Dr. Edward
Morrisey, an internationally renowned scientist in the study of lung regeneration who has defined many key
regulators of cell fate and signaling mechanisms in the lung. I have also assembled an advisory committee of
experts in vascular biology, mouse and human organoid culture, epigenetics, and bioinformatics who will assist
me with additional training in these areas. The proposed work will be conducted at the University of Pennsylvania,
where I will benefit from the rich intellectual environment, extensive resources, collaborative scientific community
in pulmonary and vascular biology, and the full support of the institution. Together, my proposed research and
career development plans will facilitate a better understanding of the role of EC signaling in lung regeneration
and aid in establishing my career as an independent investigator in pulmonary vascular biology.
项目概要
肺在体内平衡中的一个关键功能是通过一个称为“呼吸”的过程将氧气输送到血液中。
气体交换。当肺功能正常时,I型肺泡上皮细胞和毛细血管内皮细胞
远端肺血管内壁细胞(EC)形成紧密的界面来交换氧气和二氧化碳
他们之间。然而,当肺部因慢性疾病、癌症或流感等感染而受损时
或 COVID-19,这一过程可能会受到阻碍甚至阻止。肺损伤后,祖细胞可以再生
气体交换所需的细胞类型,但细胞间通讯对于形成功能性细胞也至关重要
恢复向血液输送氧气的结构。改进再生疗法的开发
因此,肺不仅需要详细了解存在的特定细胞类型,还需要了解如何
它们通过交流来驱动细胞自组织和形态发生。我们已经证明,毛细血管内皮细胞
远端肺是异质的;一个群体充当 EC 祖细胞并在急性损伤后增殖
(CAP2s),而第二个群体在受伤后不会显着增殖,并且拥有更大、更多的
复杂的形态和信号分子(CAP1s)的高表达。这些 EC 亚型明显有助于
与再生不同,但不同的 EC 命运是如何建立和维持的,其机制
促进 CAP2 的优先增殖,而 CAP1 的信号传导功能仍不清楚。此外,
肺泡微环境中影响形态发生和重建肺泡微环境所需的 EC 信号机制
气体交换界面仍然不完全清楚。拟议的研究将进一步发展我的技能
转录组和表观基因组分析来解决这些问题,并将这些技能与我的
之前在小鼠遗传学、信号传导和细胞行为方面的培训,为以后的研究奠定了坚实的基础
建立独立的研究生涯。我的研究项目将重点关注 EC 信号传导和行为的作用
急性损伤后肺功能性肺泡结构的再生。我的主要导师是爱德华博士
莫里西(Morrisey)是一位国际知名的肺再生研究科学家,他定义了许多关键的
肺部细胞命运和信号传导机制的调节者。我还组建了一个咨询委员会
血管生物学、小鼠和人类类器官培养、表观遗传学和生物信息学专家将提供协助
我在这些领域接受了额外的培训。拟议的工作将在宾夕法尼亚大学进行,
在那里我将受益于丰富的智力环境、广泛的资源、协作的科学界
在肺和血管生物学方面,以及该机构的全力支持。我提出的研究和
职业发展计划将有助于更好地了解 EC 信号在肺再生中的作用
并帮助我建立作为肺血管生物学独立研究者的职业生涯。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Terren Kathryn Niethamer其他文献
Terren Kathryn Niethamer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Terren Kathryn Niethamer', 18)}}的其他基金
Endothelial cell signaling in regeneration of the lung
肺再生中的内皮细胞信号传导
- 批准号:
10689111 - 财政年份:2022
- 资助金额:
$ 16.17万 - 项目类别:
Functions of specialized pulmonary endothelial cell types in regeneration of the lung
特殊肺内皮细胞类型在肺再生中的功能
- 批准号:
10300987 - 财政年份:2020
- 资助金额:
$ 16.17万 - 项目类别:
Defining the cellular mechanisms of craniosynostosis in a human induced pluripotent stem cell model of craniofrontonasal syndrome
定义人类颅额鼻综合征诱导多能干细胞模型中颅缝早闭的细胞机制
- 批准号:
9278002 - 财政年份:2016
- 资助金额:
$ 16.17万 - 项目类别:
Defining the cellular mechanisms of craniosynostosis in a human induced pluripotent stem cell model of craniofrontonasal syndrome
定义人类颅额鼻综合征诱导多能干细胞模型中颅缝早闭的细胞机制
- 批准号:
9123269 - 财政年份:2016
- 资助金额:
$ 16.17万 - 项目类别:
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
急性肺损伤中Hippo通路调控肺泡中间过渡态上皮细胞再生分化机制研究
- 批准号:82372185
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
土家药山姜通过调控中性粒细胞胞外捕获网的急性肺损伤保护作用及机制研究
- 批准号:82360846
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于“肠肺轴”探讨迷迭香酸通过调控肠道菌群对LPS致急性肺损伤小鼠的保护作用及其机制
- 批准号:32360897
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
肺泡巨噬细胞外泌体miR-122-5p调控肺泡II型上皮细胞自噬在脓毒症急性肺损伤中的作用及机制
- 批准号:82360024
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Targeting mechanisms activating ion-channel for preventing acute lung injury
激活离子通道的靶向机制预防急性肺损伤
- 批准号:
10659781 - 财政年份:2023
- 资助金额:
$ 16.17万 - 项目类别:
AP-1 as a transcriptional regulator of AT2 cell reversible activation during lung injury response
AP-1 作为肺损伤反应期间 AT2 细胞可逆激活的转录调节因子
- 批准号:
10535199 - 财政年份:2022
- 资助金额:
$ 16.17万 - 项目类别:
Prdm3/16 Regulate Chromatin Accessibility to Determine Alveolar Maturation
Prdm3/16 调节染色质可及性以确定肺泡成熟度
- 批准号:
10636860 - 财政年份:2022
- 资助金额:
$ 16.17万 - 项目类别:
AP-1 as a transcriptional regulator of AT2 cell reversible activation during lung injury response
AP-1 作为肺损伤反应期间 AT2 细胞可逆激活的转录调节因子
- 批准号:
10843725 - 财政年份:2022
- 资助金额:
$ 16.17万 - 项目类别:
Defining PRC2 complex epigenomic control in alveolar progenitor cells
定义肺泡祖细胞中 PRC2 复杂的表观基因组控制
- 批准号:
10560727 - 财政年份:2022
- 资助金额:
$ 16.17万 - 项目类别: